NAD+ (nicotinamide adenine dinucleotide) supplements — NMN, NR, and Niagen — reliably raise blood NAD+ levels in human trials, but evidence for downstream clinical benefits beyond that biochemical change is still early. All three are precursor compounds your body converts into NAD+, a molecule your cells use to make energy and repair themselves that declines as you age. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the two best-studied forms; Niagen is a brand-name patented form of NR chloride.
The research has moved fast in the past five years but is still catching up to the marketing claims. Trials reliably show that these supplements raise blood NAD+ levels — the Conze trial of Niagen, for example, showed dose-dependent increases of 22%, 51%, and 142% across three doses. The harder question — whether higher NAD+ actually makes you live longer, feel more energetic, or perform better in daily life — is still being studied.
This guide walks through what NAD+ does, how NMN, NR, and Niagen differ, what the human trials actually show, side effects and safety, a head-to-head comparison, and how to think about supplementation if you’re considering it.
What NAD+ is and why people supplement it
NAD+ is a molecule your cells use to make energy, repair DNA, and keep mitochondria (the cellular structures that produce energy) working well. It’s involved in hundreds of processes across every tissue.
NAD+ levels appear to decline as you age, with measurements suggesting meaningful drops by middle age, though the precise drop varies by tissue, person, and measurement method. The idea behind NAD+ supplementation — popularized by researchers like David Sinclair and clinicians like Peter Attia — is that restoring those levels could push back against age-related decline in cellular energy and repair.
Your body makes NAD+ from a small set of precursor molecules. The two that have been studied most as supplements in humans are NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide). Niagen is a brand-name patented form of NR sold as a branded ingredient in many over-the-counter supplements (Tru Niagen, Basis, and others).
NMN, NR, and Niagen — what’s the difference
NMN and NR are both raw materials your body converts into NAD+. They’re closely related — NMN is one step closer to NAD+, and ongoing research is sorting out whether oral NMN reaches your cells intact or is broken down to NR first in the gut. Whether the route taken affects how well NMN works versus NR is still debated; what’s clear is that both raise blood NAD+ levels when you take them.
NMN (nicotinamide mononucleotide) has been studied for muscle insulin sensitivity, aerobic capacity, and sleep quality, with mostly positive findings on the biochemistry side and mixed-to-promising findings on the clinical side.
NR (nicotinamide riboside) has been studied longer and in more trials than NMN, with the largest body of safety and dosing data in humans.
Niagen is a brand-name patented form of NR — the same molecule as generic NR but with specific manufacturing and quality testing behind it. Products like Tru Niagen and Basis use Niagen as their active ingredient. When you pay extra for a “Niagen” supplement, you’re paying for the brand and the quality control, not a different molecule.
The simple way to think about it: NMN and NR both end up at the same place — NAD+ in your cells. The differences are in how they get there, how much evidence each has behind it, and what they cost.
What the human trials actually show
Three human randomized controlled trials (RCTs) anchor the strongest evidence base for NAD+ precursor supplementation:
Yoshino et al. 2021 (Science) — a randomized, placebo-controlled trial of 250 mg/day NMN for 10 weeks in 25 prediabetic, overweight or obese postmenopausal women found a significant increase in muscle insulin sensitivity (~25%) in the NMN group versus placebo (Yoshino et al., Science 2021, PMID 33888596). This was a small but well-conducted trial in a specific population; it doesn’t directly generalize to healthy adults.
Yi et al. 2023 (Geroscience) — a multicenter, double-blind, placebo-controlled, dose-dependent NMN trial in 80 healthy middle-aged adults tested 300, 600, and 900 mg/day for 60 days. The NMN groups had dose-dependent increases in blood NAD+ levels and improved performance on the 6-minute walk test, an exploratory functional endpoint; no significant safety concerns were reported (Yi et al., Geroscience 2023, PMID 36482258).
Conze et al. 2019 (Scientific Reports) — an 8-week randomized, double-blind, placebo-controlled trial of Niagen (NR chloride) at 100, 300, and 1000 mg/day in 140 healthy overweight adults showed dose-dependent increases in whole blood NAD+ of 22%, 51%, and 142%, with no clinically significant safety findings (Conze et al., Sci Rep 2019, PMID 31278280). The trial was sponsored by ChromaDex, the maker of Niagen, with this conflict disclosed in the published paper.
The consistent finding: NAD+ precursor supplementation reliably increases blood NAD+ levels at standard doses. The harder question — whether these biochemical changes translate to longevity, healthspan, energy, or disease-prevention benefits at population scale — has weaker, more heterogeneous evidence. Most longer-duration trials are still in progress, and results so far have been mixed across endpoints (cognition, cardiovascular markers, muscle function, sleep quality).
Side effects and safety
Across the published RCTs, NMN and NR (including Niagen) have been well tolerated at the doses studied (100-1,000+ mg/day) over weeks to months. Common reported side effects when they occur are mild and dose-dependent:
- Nausea, particularly at higher doses or on an empty stomach
- Headache
- Flushing of the face or chest (much more common with regular niacin than with NR or NMN)
- Stomach discomfort or diarrhea
- Sleep disruption if dosed late in the day (some users find better tolerance with morning dosing)
Most published trials run weeks to months; long-term safety over years has not been extensively studied. There are theoretical concerns about NAD+ supplementation in people with active cancer (since NAD+ is also a substrate that fast-growing cells use), but high-quality clinical data is lacking; this is an area where clinical caution and oncologist consultation are warranted.
Important: NAD+ supplements may have interactions with prescription medications (including some chemotherapy agents and certain neurological drugs). If you have a diagnosed medical condition, are pregnant or breastfeeding, or take prescription medications, discuss NAD+ supplementation with your clinician or pharmacist before starting.
NMN vs NR vs Niagen — head-to-head comparison
| Form | Typical dose range (from cited RCTs) | Evidence quality | Approx. monthly cost (US, 2026 estimate, varies by brand) | Best supported for |
|---|---|---|---|---|
| NMN (nicotinamide mononucleotide) | 250-900 mg/day | Multiple small-to-medium RCTs; mostly biochemical endpoints; some clinical (insulin sensitivity, walking endurance) positive | $40-$80 | Older or metabolically compromised adults seeking biochemical NAD+ restoration |
| NR (nicotinamide riboside) | 100-1,000 mg/day | Larger evidence base; multiple RCTs; mostly biochemical with some clinical endpoints (cardiovascular markers, muscle) | $25-$60 | People wanting the most-studied NAD+ precursor and willing to use the generic form |
| Niagen (branded NR chloride) | 100-1,000 mg/day (same as NR — same molecule) | Same as NR (the underlying molecule); branded clinical-trial evidence specifically on Niagen formulations | $45-$90 | People preferring a branded ingredient with manufacturer-tested purity and supply chain |
A few practical takeaways from this comparison:
- NMN and NR end up at the same destination — NAD+ in your cells. The question is which one is more bioavailable in your body. Direct head-to-head human trials comparing NMN and NR are rare; available data suggests similar efficacy for blood NAD+ elevation.
- Niagen is the same molecule as generic NR — you’re paying a premium for branded manufacturing, third-party purity testing, and the clinical-trial portfolio specific to Niagen.
- Dose-response is real — higher doses produce larger NAD+ increases in both NMN and NR trials, but the marginal benefit on clinical endpoints isn’t proportional. 300 mg often performs similarly to 600+ mg on clinical outcomes in trial data.
- Quality matters — supplement label claims and actual content can vary in this category. Third-party tested products are preferable.
How to think about NAD+ supplementation
If you’re considering an NAD+ booster, a reasonable framework:
- Set realistic expectations. The strongest evidence is for raising blood NAD+ levels. Whether you feel a difference (energy, sleep, performance) varies considerably by person and isn’t guaranteed.
- Start with the better-evidenced option for your goal. For general NAD+ restoration, NR/Niagen has more long-duration trial data. For specific metabolic endpoints (muscle insulin sensitivity), NMN has the strongest single-trial evidence in older adults.
- Choose a third-party tested product. Supplements that carry independent quality-testing seals (like USP, NSF, or Informed Sport) have been verified to contain what their label says.
- Use a standard dose. Most evidence-supported doses sit between 250 mg and 1,000 mg per day. Going higher costs more without consistently producing larger benefits in trial data.
- Track outcomes that matter to you. Resting heart rate, HRV, sleep quality, and subjective energy are reasonable indicators. A 4-8 week trial period — in line with the trial durations in the cited RCTs above (8-10 weeks) — with a specific metric in mind is more useful than open-ended supplementation.
- Run it past your clinician if you have any medical conditions, take prescription medications, or are in cancer treatment.
For context on how to read the kind of nocturnal vitals (HRV, RHR, sleep stages) that may shift with effective supplementation, see Ultrahuman’s sleeping heart rate guide and parasympathetic vs sympathetic guide.
This article is for informational purposes and is not medical advice. NAD+ supplements are not regulated as drugs and individual responses vary. If you have a medical condition, are pregnant or breastfeeding, take prescription medications, or are undergoing cancer treatment, discuss NAD+ supplementation with your clinician before starting. Disclosure: Ultrahuman sells the Ring AIR and Ring PRO, which track nocturnal vitals (resting heart rate, HRV, skin temperature, sleep stages) that some people use as outcome measures for supplementation experiments. Ultrahuman does not sell NAD+ supplements and has no commercial interest in any specific NMN, NR, or Niagen brand.
